A double-blind randomised controlled trial on the effect of Tocovid, a tocotrienol-rich capsule on postoperative atrial fibrillation at the National Heart Institute, Kuala Lumpur: an interim blinded analysis

Ahmad Farouk Musa, Jeswant Dillon, Mohamed Ezani Md Taib, Alwi Mohamed Yunus, Abdul Rais Sanusi, Mohd Nazeri Nordin, Julian A Smith, Ahmad Farouk Musa, Jeswant Dillon, Mohamed Ezani Md Taib, Alwi Mohamed Yunus, Abdul Rais Sanusi, Mohd Nazeri Nordin, Julian A Smith

Abstract

Introduction: Post-operative atrial fibrillation (POAF) is associated with poorer outcomes, increased resource utilisation, morbidity and mortality. Its pathogenesis is initiated by systemic inflammation and oxidative stress. It is hypothesised that a potent antioxidant and anti-inflammatory agent such as tocotrienol, an isomer of Vitamin E, could reduce or prevent POAF.

Aims: The aim of this study is to determine whether a potent antioxidative and anti-inflammatory agent, Tocovid, a tocotrienol-rich capsule, could reduce the incidence of POAF and affect the mortality and morbidity as well as the duration of ICU, HDU and hospital stay.

Methods: This study was planned as a prospective, randomised, controlled trial with parallel groups. The control group received placebo containing palm superolein while the treatment group received Tocovid capsules. We investigated the incidence of POAF, the length of hospital stay after surgery and the health-related quality of life.

Results: Recruitment commenced in January 2019 but the preliminary results were unblinded as the study is still ongoing. Two-hundred and two patients have been recruited out of a target sample size of 250 as of January 2021. About 75% have completed the study and 6.4% were either lost during follow-up or withdrew; 4% of participants died. The mean age group was 61.44 ± 7.30 years with no statistical difference between the groups, with males having a preponderance for AF. The incidence of POAF was 24.36% and the mean time for developing POAF was 55.38 ± 29.9 h post-CABG. Obesity was not a predictive factor. No statistically significant difference was observed when comparing left atrial size, NYHA class, ejection fraction and the premorbid history. The mean cross-clamp time was 71 ± 34 min and the mean bypass time was 95 ± 46 min, with no difference between groups. There was a threefold increase in death among patients with POAF (p = 0.008) and an increase in the duration of ICU stay (p = 0.01), the total duration of hospital stay (p = 0.04) and reintubation (p = 0.045).

Conclusion: A relatively low incidence rate of POAF was noted although the study is still ongoing. It remains to be seen if our prophylactic intervention using Tocovid would effectively reduce the incidence of POAF. Clinical Registration Number: US National Library of Medicine. Clinical Trials - NCT03807037. Registered on 16th January 2019. Link: https://ichgcp.net/clinical-trials-registry/NCT03807037.

Keywords: CABG; Health-related quality of life (HRQoL); Length of hospital stay (LoHS); Morbidity; Mortality; Post-operative atrial fibrillation (POAF); Tocovid.

Conflict of interest statement

No competing interests were disclosed.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Study flow chart

References

    1. D’Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW, et al. The society of thoracic surgeons adult cardiac surgery database: 2018 update on outcomes and quality. Ann Thorac Surg. 2018;105(1):15–23.
    1. Musa AF, Quan CZ, Xin LZ, Soni T, et al. A retrospective study on atrial fibrillation after coronary artery bypass grafting surgery at the National Heart Institute, Kuala Lumpur. F1000 Res. 2018;7:164.
    1. Ramlawi B, Otu H, Mieno S, Boodhwani M, Sodha NR, Clements RT, Bianchi C, Sellke SW. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control stusy. Ann Thorac. 2007;84:1166–1173.
    1. Zakkar M, Ascione R, James AF, Angelini GD, Suleiman MS. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015;154:13–20.
    1. St-Onge S, Perrault LP, Demers P, Boyle EM, Gillinov AM, Cox J, Melby S. Pericardial blood as a trigger factor for postoperative atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2018;105:321–328.
    1. LaPar DJ, Speir AM, Crosby IK, Fonner E, Jr, Brown M, Rich JB, Quader M, Kern JA, Kron IL, Ailawadi G, Investigators for the Virginia Cardiac Surgery Quality Initiative Postopeartive atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014;98(2):527–533.
    1. Steinberg BA, Zhao Y, He X, Hernandez AF, Fullerton DA, Thomas KL, Mills R, Klaskala W, Peterson ED, Piccini JP. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from The Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin Cardiol. 2014;37(1):7–13.
    1. Rostgano C, LaMeir M, Gelsomino S, Ghili L, Rossi A, Carone E, Braconi L, Rosso G, Puggelli F, Mattesini A, Stafàno PL, Padeletti PL, Maessen J, Gensini GF. Atrial fibrillation after cardiac surgery: incidence, risk factors, and economic burden. J Cardiothorac Vasc Anesth. 2010;24(6):952–958.
    1. Goldstein RN, Ryu K, Khrestian C, Van Wagoner DR, Waldo AL. Prednisolone prevents inducible atrial flutter in the canine sterile pericarditis model. J Cardiovasc Electrophysiol. 2008;19(1):78–81.
    1. Chen MC, Chang JP, Liu WH, Yang CH, Chen YL, Tsai TH, Wang YH, Pan KL. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol. 2008;102(7):861–865.
    1. Mozaffarian D, Wu JHY, Otto MCDO, Sandesara CM, Metcalf RG, Latini R, Libby P, Lambardi F, O’Gara PT, Page RL, Siletta MG, Tavazzi L, Marchioli R. Fish-oil and post-operative atrial fibrillation—a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2013;61(21):2194–2196.
    1. Zhang B, Zhen Y, Tao A, Bao Z, Zhang G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. J Cardiol. 2014;63(1):53–59.
    1. Baker WL, Coleman CI. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am J Health Syst Pharm. 2016;73(24):256–266.
    1. Ahsan H, Ahad A, Iqbal J, Siddiqui WA. Pharmacological potentials of tocotrienols: a review. Nutr Metab. 2014;11(1):52.
    1. Peh HY, Tan WS, Liao W, Wong WS. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther. 2016;162:152–169.
    1. Stanger O, Aigner I, Schimetta W, Wonisc W. Antioxidant supplementation attenuates oxidative stress in patients undergoing coronary artery bypass graft surgery. Tohoku J Exp Med. 2014;232:145–154.
    1. Yap SP, Yuen KH, Lim AB. Influence of route of administration on the absorption and disposition of α-, γ- and δ-tocotrienols in rat. J Pharm Pharmacol. 2003;55:53–58.
    1. Gopalan Y, Shuaib IB, Magosso E, Ansari MA, et al. Clinical Investigation of the protective effects of palm vitamin E tocotrienols on brain white matter. Stroke. 2014;45:1422–1428.
    1. Magosso E, Ansari MA, Gopalan Y, Shuhaib IB, et al. Tocotrienols for normalisation of hepatic echogenic response in non-alcoholic fatty liver: a randomised placebo-controlled trial. Nutr J. 2013;12:166–174.
    1. Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O'Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G. The ω-3 fatty acids for prevention of post-operative atrial fibrillation trial—rationale and design. Am Heart J. 2011;162(1):56–63.
    1. Jenkinson C. The SF-36 physical and mental health summary measures: an example of how to interpret scores. J Health Serv Res Policy. 1998;3:92–96.
    1. Musa AF, Yasin MSM, Smith J, Yakub MA, Nordin RB. The Malay version of SF-36 health survey instrument: testing data quality, scaling assumptions, reliability and validity in post-coronary artery bypass grafting (CABG) patients at the National Heart Institute (Institut Jantung Negara – IJN), Kuala Lumpur. Health Life Qual Outcomes. 2021;19:50.
    1. Valle JSR, Ejheisheh MA, Membrive-Jiménez MJ, et al. Quality of life after coronary artery bypass surgery: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17:8439.
    1. Wittes J. Sample size calculations for randomized controlled trials. Epidemiol Rev. 2002;24(1):39–56.
    1. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials. 1990;11:116–128.
    1. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19:589–601.
    1. Saravanan P, Bridgewater B, West AL, O’Neill SC, Calder PC, Davidson NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo controlled clinical trial. Circ Arrythmia Electrophysiol. 2009;3:46–53.
    1. Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723–1728.
    1. Musa AF, Cheong XP, Dillon J, Nordin RB. Validation of EUROScore II in patients undergoing coronary artery bypass grafting (CABG) surgery at the National Heart Institute, Kuala Lumpur: a retrospective review. F1000 Res. 2018;7:534.
    1. Philip I, Berroeta C, Leblanc I. Perioperative challenges of atrial fibrillation. Curr Opin Anaesthesiol. 2014;27:344–352.
    1. Shen J, Lall S, Zheng V, et al. The persistent problem of new onset post-operative atrial fibrillation: a single institution experience over two decades. J Thorac Cardivasc Surg. 2011;141:559–570.
    1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on the Practice Guidelines and Heart Rhythm Society. J Am Coll Cardiol. 2013;64:e1–76.
    1. Mitchell LB, CCS Atrial Fibrillation Guidelines Committee Canadian Cardiovascular Society atrial fibrillation guidelines 2012: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol. 2011;27(1):91–97.
    1. Echaidi N, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51:793–801.
    1. Chandy J, Nakai T, Lee RJ, Bellows WJ, Dzankic S, Leung JM. Increases in p-wave dispersion predicts post-operative atrial fibrillation after coronary artery bypass graft surgery. Anaesth Analg. 2004;98:303–310.
    1. Filardo G, Ailawadi G, Pollock BD, Graca BD, Phan TK, Thourani V, Damiano-Jr RJ. Post-operative atrial fibrillation: sex-specific characteristics and effect on survival. J Thorac Cardiovasc Surg. 2020;159(4):1419–1425.
    1. Zhang W, Liu W, Chew ST, et al. A clinical prediction model for post-cardiac surgery atrial fibrillation in an Asian population. Anaesth Analg. 2016;123(2):283–289.
    1. Benedetto U, Gaudino M, Dimagli A, et al. Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery. Circulation. 2020;142:1320–1329.
    1. WHO International: 2019; Link: Malaysia has the highest rate of obesity and overweight among Asian countries with 64% of male and 65% of female population being either obese or overweight. Accessed 18 Feb 2021.
    1. The Asia-Pacific perspective: Redefining obesity and its treatment. IASO International Association for the study of obesity; World Health Organization, Western Pacific Region. 2000.
    1. Phan K, Khuong JN, Xu J, Kanagaratnam A, Yan TD. Obesity and post-operative atrial fibrillation in patients undergoing cardiac surgery: systematic review and meta-analysis. Int J Cardiol. 2016;217:49–57.
    1. Serban C, Arinze JT, Starreveld R, Lanters EAH, Yaksh A, Kik C, et al. The impact of obesity on early post-operative atrial fibrillation burden. J Thorac Cardiovasc Surg. 2020;159:930–38e2.
    1. Perrier S, Meyer N, Hoang-Minh T, Announe T, Bentz J, Billaud P, et al. Predictors of atrial fibrillation after coronary artery bypass grafting: a Bayesian analysis. Ann Thorac Surg. 2017;103:92–97.
    1. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70:2022–2035.
    1. Sun X, Boyce SW, Hill PC, Bafi AS, Xue Z, Lindsay J, Corso PJ. Association of body mass index with new-onset atrial fibrillation after coronary artery bypass grafting operations. Ann Thorac Surg. 2011;91:1852–1859.
    1. Ismail MF, El-Mahrouk AF, Hamouda TH, Radwan H, Haneef A, Jamjoom AA. Factors influencing post-operative atrial fibrillation in patients undergoing on-pump coronary artery bypass grafting: single center experience. J Cardiothorac Surg. 2017;12:40.
    1. Straus S, Kacila M, Omerbasic E, Mujičić E. Atrial fibrillation and coronary bypass surgery—what can be risk factors for its appearance? Bosnian J Basic Med Sci. 2010;10(1):78–82.
    1. El-Gendy A, Dabsha MH, Elewa GM, Ali AH. Predictors of post-operative atrial fibrillation after coronary artery bypass grafting: a prospective observational cohort study. Ain-Shams J Anaesthesiol. 2020;12:55.
    1. Basaran O, Tigen K, Gözübüyük G, Dündar C, et al. Predictive role of left atrial and ventricular mechanical function in post-operative atrial fibrillation a two-dimensional speckle-tracking echocardiography study. Turk Kardiyol Dem Ars. 2016;44(1):45–52.
    1. Hashemzadeh K, Dehdilani M, Dehdilani M. Postoperative atrial fibrillation following open cardiac surgery: predisposing factors and complications. J Cardivoasc Thorac Res. 2013;5(3):103–107.
    1. Sammoud K, Lajmi M, Touhami F, Hfayedh A, Lahdhili H, Chenik S. Predictive factors of new onset atrial fibrillation in cardiac surgery. Arch Cardiovasc Dis Supp. 2019;11(1):141–142.
    1. Benedetto U, Albanese A, Kattach H, Rugiero D, Robertis FD, Amrani M, Raja SG. Smoking cessation before coronary artery bypass grafting improves operative outcomes. J Thorc Cardiovasc Surg. 2014;148(2):468–474.
    1. Villareal RP, Hariharan R, Liu BC, Kar B, Lee W, Elyada M, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–748.
    1. Mitchell LB, CCS Atrial Fibrillation Guidelines Committee Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation after cardiac surgery. Can J Cardiol. 2011;27:91–97.
    1. Zakkar M, Ascione R, James AF, Angelini GD, Suleiman MS. Inflammation, oxidative stress, and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015;154:13–20.
    1. Yadava M, Hughey AV, Crawford TC. Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates. Heart Fail Clin. 2016;12:299–308.
    1. Attaran S, Shaw M, Bond L, Pullman MD, Fadri BM. Atrial fibrillation post-cardiac surgery: a common but morbid complication. Interact Cardiovasc Thorac Surg. 2011;12:772–777.
    1. Thorén E, Wernroth M-L, Christersson C, Ginnemo K-H, Jidéus L, Stähle E. Compared with match-controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischaemic stroke, heart failure, and mortality even after adjustment for AF. Clin Res Cardiol. 2020;109:1232–1242.
    1. Matthew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. Multicenter Study of Perioperative Ischemia Research Group. JAMA. 1996;278:300–306.
    1. Melby SJ, George JF, Picone DJ, Davies JE, George D, et al. A time-related parametric risk factor analysis for postoperative atrial fibrillation after heart surgery. J Thorac Cardiovasc Surg. 2015;109:886–892.
    1. Greenberg JW, Lancaster TS, Schuessler SB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52(4):665–672.
    1. Hernández-Leiva E, Alvarado P, Dennis RJ. Postoperative atrial fibrillation: evaluation of its economic impact on the cost of cardiac surgery. Braz J Cardiovasc Surg. 2019;34(2):179–186.
    1. Akintoye E, Selke F, Marchioli R, Tavazzi L, Mozaffarian D. Factors associated with post-operative atrial fibrillation and other adverse events after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(1):242–251.
    1. Al-Massi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FI. Predictors and impact of postoperative atrial fibrillation on patients’ outcomes: a report from the Randomised On Versus Off Bypass trial. J Thorac Cardiovasc Surg. 2012;143(1):93–102.
    1. Al-Massi GH, Wagner TH, Carr B, Hattler B, Collins JF, Quin JA, et al. Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass trial. Ann Thorac Surg. 2015;99(1):109–114.
    1. Steinberg BA, Zhao Y, He X, Hernandez AF, Fullerton DA, Thomas KL, et al. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin Cardiol. 2014;37(1):7–13.
    1. Ishi Y, Schuessler RB, Gaynor SL, Yamada K, Fu AS, Boineau AJP, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005;111:2881–2888.
    1. Kramer PA, Chacko BK, Ravi S, Johnson MS, Mitchell T, Barnes S, et al. Haemoglobin-associated oxidative stress in the pericardial compartment of postoperative cardiac surgery patients. Lab Investig. 2015;95:132–141.
    1. Kramer PA, Chacko BK, George DJ, Zhi D, Wei CC, Dell’Italia LJ, et al. Decreased bioenergetic health index in monocytes isolated from the pericardial fluid and blood of postoperative cardiac surgery patients. Biosci Rep. 2015;35(4):e00237.
    1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720–1729.
    1. Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(3):313–320.
    1. Wolowacs SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder JC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011;13(10):1375–1385.
    1. Burrage PS, Low YH, Campbell NG, O’Brien B. New-onset atrial fibrillation in adult patients after cardiac surgery. Curr Anesthesiol Rep. 2019;9(2):174–193.
    1. Gorenek B, Pellicia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van-Gelder IC, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and the Asia Pacific Heart Rhythm Society (APHRS) Eur J Prev Cardiol. 2017;24(1):4–40.
    1. Rubanenko O, Rubanenko A. The effect of Omega-3 polyunsaturated fatty acids in prevention of postoperative atrial fibrillation development in patients undergoing coronary artery bypass graft surgery. Eur J Prev Cardiol. 2021;28(Suppl):1.
    1. Langlois PL, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in cardiac surgery patients: an updated systematic review and meta-analysis. Clin Nutr. 2017;36(3):737–746.
    1. Wang H, Chen J, Zhao L. N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review. J Interv Card Electrophysiol. 2018;51(2):105–115.
    1. Ali-Hassan Al-Saegh S, Mirhosseini SJ, Tabernejad M, Mahdavi P, Shahidzadeh A, Karim-Bondarabadi AA, et al. Impact of antioxidant supplementation on cardi-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review. Cardiovasc Ther. 2016;34(5):360–370.
    1. Mirmohammadsadeghi M, Mirmohammmadsadeghi A, Mahmoudian M. Preventive use of ascorbic acid for atrial fibrillation after coronary artery bypass graft surgery. Heart Surg Forum. 2018;21(5):E415–E417.
    1. Rodrigo R, Korantzopoulos P, Cereceda M, Asenio R, Zamarano J, Vilalabeitia E, et al. A randomized controlled trial in prevent post-operative atrial fibrillation by antioxidant reinforcement. J Am Coll Cardiol. 2013;62(16):1457–1465.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe